send to a friend by email

JPH records net income of $2.16 million in 2013

2014-02-17

According to Jerusalem Pharmaceuticals data for year-end preliminary financial statements for year 2013, net profit after taxes reached 2,162,958 USD, compared with a net profit after taxes of 195,590 USD in the audited data for 2012, a net increase of 1005.9%. Total assets of the company reached 53,816,180 USD as of December 31^st, 2013, compared to total assets of 48,875,519 USD as of December 31^st, 2012, a net increase of 10.1%. Total liabilities of the company reached 16,238,960 USD as of December 31^st, 2013, compared to total liabilities of 15,164,804 USD as of December 31^st, 2012, a net increase of 7.1%. Net ownership equity of the company reached 37,577,220 USD (including 722,680 USD in Non-controlling interest) as of December 31^st, 2013, compared with a net ownership equity of 33,710,715 USD (including 959,077 USD in Non-controlling interest) as of December 31^st, 2012, a net increase of 11.5%. Furthermore, paid-in capital increased from 8,530,000 USD  on December 31^st, 2012 to 17,060,000 USD  by December 31^st, 2013, an increase of 100.0%.